Better Therapeutics, Inc. Common Stock
BTTX
BTTX was delisted on the 15th of March, 2024.
3 hedge funds and large institutions have $1.45K invested in Better Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 19 closing their positions.
86% less funds holding
Funds holding: 22 → 3 (-19)
99% less capital invested
Capital invested by funds: $281K → $1.45K (-$280K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$65.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$42.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$38.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$32.9K |
| 5 |
Millennium Management
New York
|
-$25.1K |
BTTX Hedge Fund Activity: Q1 2024 in Review
3 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Better Therapeutics, Inc. Common Stock (BTTX) for Q1 2024, worth a combined $1.45K — down 99% from $281K a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BTTX and 0 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was XTX Topco, adding an estimated $3.35K. The largest seller was MMCAP International, exiting entirely with an estimated $65.2K sold.
- 3 institutional investors held Better Therapeutics, Inc. Common Stock (BTTX) as of Q1 2024, down from 22 in Q4 2023.
- Funds reported $1.45K of Better Therapeutics, Inc. Common Stock stock for Q1 2024, down 99% quarter-over-quarter.
- 0 funds opened new Better Therapeutics, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of -19 holders.
- The largest Better Therapeutics, Inc. Common Stock buyer in Q1 2024 was XTX Topco, an estimated $3.35K added.
- The largest Better Therapeutics, Inc. Common Stock seller in Q1 2024 was MMCAP International, an estimated $65.2K sold.
Based on aggregated 13F filings for Q1 2024.